郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.

期刊：Journal of medicinal chemistry发表年份：2007作者：Bernat Vidal; Arsenio Nueda; Cristina Esteve; Teresa Domenech; Sonia Benito; Raquel F Reinoso; Mercè Pont; Marta Calbet; Rosa López; María Isabel Cadavid; María Isabel Loza; Alvaro Cárdenas; Núria Godessart; Jorge Beleta; Graham Warrellow; Hamish Ryd
阅读更多 →

药效评价1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.

期刊：Bioorganic & medicinal chemistry letters发表年份：2007作者：Adrian Hall; Susan H Brown; Iain P Chessell; Anita Chowdhury; Nicholas M Clayton; Tanya Coleman; Gerard M P Giblin; Beverley Hammond; Mark P Healy; Matthew R Johnson; Ann Metcalf; Anton D Michel; Alan Naylor; Riccardo Novelli; David J Spalding; Jenni
阅读更多 →

药效评价Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein.

期刊：Circulation research发表年份：2007作者：Alan T Remaley
阅读更多 →

药效评价Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists.

期刊：Bioorganic & medicinal chemistry letters发表年份：2007作者：John A Wendt; Susan D Deeter; Susan E Bove; Christopher S Knauer; Rachel M Brooker; Corinne E Augelli-Szafran; Roy D Schwarz; Jack J Kinsora; Kenneth S Kilgore
阅读更多 →